Protohypericin
CAS No. 548-03-8
Protohypericin ( —— )
Catalog No. M21814 CAS No. 548-03-8
Protohypericin is a naturally occurring naphthodianthrone derived from plant Hypericum perforatum. Radioiodinated protohypericin is used in Tumor necrosis targeted radiotherapy.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 249 | In Stock |
|
10MG | 426 | In Stock |
|
25MG | 683 | In Stock |
|
50MG | 888 | In Stock |
|
100MG | 1242 | In Stock |
|
500MG | 2511 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameProtohypericin
-
NoteResearch use only, not for human use.
-
Brief DescriptionProtohypericin is a naturally occurring naphthodianthrone derived from plant Hypericum perforatum. Radioiodinated protohypericin is used in Tumor necrosis targeted radiotherapy.
-
DescriptionProtohypericin is a naturally occurring naphthodianthrone derived from plant Hypericum perforatum. Radioiodinated protohypericin is used in Tumor necrosis targeted radiotherapy.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number548-03-8
-
Formula Weight506.46
-
Molecular FormulaC30H18O8
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(C1=C(O)C=C(C)C=C1C2=C34)C3=C(O)C=C(O)C4=C5C(O)=CC(O)=C6C(C7=C(O)C=C(C)C=C7C2=C65)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Baugh SF. Simultaneous determination of protopseudohypericin, pseudohypericin, protohypericin, and hypericin without light exposure. J AOAC Int. 2005 Nov-Dec;88(6):1607-12.
2. Liu X, et al. Tumor necrosis targeted radiotherapy of non-small cell lung cancer using radioiodinated protohypericin in a mouse model. Oncotarget. 2015 Sep 22;6(28):26400-10.
molnova catalog
related products
-
3-Isomangostin
3-Isomangostin is an acetylcholinesterase selective inhibitor and a potent human aldose reductase inhibitor with an IC50 of 3.48 uM.
-
CP-24879 hydrochlori...
CP-24879 hydrochloride, a Δ5D/Δ6D dual-inhibitor, can significantly reduce intracellular lipid accumulation and inflammatory injury in hepatocytes. CP-24879 hydrochloride exhibits superior antisteatotic and anti-inflammatory actions in fat-1 and ω-3-treated hepatocytes.
-
Eculizumab
Eculizumab is a recombinant humanized monoclonal antibody against the complement protein C5.